Welcome to Markets Desk, your midday read on what's moving and why.
Soft commodities are commanding attention across the board today. Cocoa led the charge, with ICE New York futures surging more than five and a half percent after Ghana's COCOBOD projected a weaker harvest for the twenty twenty six to twenty twenty seven season. Ghana is the world's second largest cocoa producer, and any supply disruption there ripples straight through to chocolate makers and consumer goods pricing globally.
Sugar moved in sympathy, closing up roughly one and a half percent in New York as traders covered short positions following fresh concerns over India's monsoon-dependent crop. India is a critical swing producer in global sugar markets, and when its Meteorological Department flags rainfall uncertainty, the market listens. Arabica coffee joined the rally as well, settling nearly three percent higher as ICE-certified inventories continued a decline that has now stretched across four and a half months, tightening near-term supply and pushing roasters toward the spot market.
Shifting to healthcare, Gilead Sciences remains in focus around its HIV prevention drug lenacapavir, which has shown nearly one hundred percent efficacy in trials with just two injections per year. The challenge now is distribution, particularly in Latin American nations that helped run the trials but face significant pricing and access barriers to actually receiving the drug.
That's the tape. Markets Desk, signing off the floor.
